T1	tradename 111 118	Mircera
T2	tradename 180 198	Mircera. Mircera
T3	nanoparticle 200 241	methoxy polyethylene glycol-epoetin beta)
T4	routeofadministration 268 284	Intravenous [IV]
T5	routeofadministration 288 305	Subcutaneous [SC]
T6	fdaapprovaldate 333 337	2007
T7	adversereaction 376 468	DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS
T8	adversereaction 473 490	TUMOR PROGRESSION
T9	adversereaction 661 667	death,
T10	adversereaction 685 710	cardiovascular reactions,
T11	adversereaction 715 721	stroke
T12	tradename 1001 1008	Mircera
T13	tradename 1108 1115	Mircera
T14	tradename 1238 1245	Mircera
T15	adversereaction 1283 1289	deaths
T16	tradename 1315 1322	Mircera
T17	adversereaction 1418 1435	tumor progression
T18	tradename 2031 2038	Mircera
T19	indication 2115 2160	anemia associated with chronic kidney disease
T20	tradename 2253 2260	Mircera
T21	tradename 2490 2497	Mircera
T22	tradename 2654 2661	Mircera
T23	routeofadministration 2681 2698	subcutaneous (SC)
T24	routeofadministration 2702 2718	intravenous (IV)
T25	dose 2764 2774	0.6 mcg/kg
T26	frequency 2800 2821	once every two weeks
T27	frequency 2873 2885	once monthly
T28	frequency 2889 2910	once every two weeks
T29	tradename 3153 3160	Mircera
T30	adversereaction 3333 3361	Pure red cell aplasia (PRCA)
T31	tradename 3395 3402	Mircera
T32	adversereaction 3466 3492	serious allergic reactions
T33	tradename 3496 3504	Mircera,
T34	adversereaction 3515 3526	anaphylaxis
T35	adversereaction 3618 3669	Increased Mortality, Myocardial Infarction, Stroke,
T36	adversereaction 3675 3691	Thromboembolism:
T37	tradename 4060 4067	Mircera
T38	adversereaction 4085 4103	Seizures: Seizures
T39	tradename 4151 4158	Mircera
T40	adversereaction 4289 4294	PRCA:
T41	adversereaction 4298 4311	severe anemia
T42	adversereaction 4316 4338	low reticulocyte count
T43	tradename 4354 4361	Mircera
T44	tradename 4382 4389	Mircera
T45	adversereaction 4407 4411	PRCA
T46	adversereaction 4556 4596	hypertension, diarrhea, nasopharyngitis.
T47	adversereaction 4990 5081	DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS
T48	adversereaction 5087 5104	TUMOR PROGRESSION
T49	indication 5149 5185	Anemia Due to Chronic Kidney Disease
T50	tradename 5371 5378	Mircera
T51	adversereaction 5461 5512	Increased Mortality, Myocardial Infarction, Stroke,
T52	adversereaction 5517 5532	Thromboembolism
T53	adversereaction 5538 5557	Increased Mortality
T54	adversereaction 5583 5600	Tumor Progression
T55	adversereaction 5661 5669	Seizures
T56	tradename 5714 5721	Mircera
T57	adversereaction 5726 5747	Pure Red Cell Aplasia
T58	adversereaction 5755 5781	Serious Allergic Reactions
T59	adversereaction 6716 6808	DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS,
T60	adversereaction 6814 6831	TUMOR PROGRESSION
T61	adversereaction 6978 6984	death,
T62	adversereaction 7001 7027	cardiovascular reactions,
T63	adversereaction 7032 7038	stroke
T64	tradename 7303 7310	Mircera
T65	tradename 7441 7448	Mircera
T66	tradename 7570 7577	Mircera
T67	adversereaction 7615 7621	deaths
T68	tradename 7647 7654	Mircera
T69	adversereaction 7756 7773	tumor progression
T70	indication 7937 7973	Anemia Due to Chronic Kidney Disease
T71	tradename 7977 7984	Mircera
T72	indication 8019 8070	anemia associated with chronic kidney disease (CKD)
T73	tradename 8163 8170	Mircera
T74	tradename 8464 8471	Mircera
T75	tradename 8919 8926	Mircera
T76	tradename 9068 9075	Mircera
T77	adversereaction 9229 9235	death,
T78	adversereaction 9255 9280	cardiovascular reactions,
T79	adversereaction 9285 9291	stroke
T80	adversereaction 9647 9652	death
T81	frequency 10160 10179	once every 4 weeks.
T82	tradename 10372 10379	Mircera
T83	tradename 10708 10715	Mircera
T84	tradename 10949 10956	Mircera
T85	tradename 10997 11004	Mircera
T86	routeofadministration 11028 11046	intravenously (IV)
T87	routeofadministration 11050 11070	subcutaneously (SC).
T88	routeofadministration 11089 11092	SC,
T89	tradename 11093 11100	Mircera
T90	tradename 11215 11222	Mircera
T91	tradename 11381 11389	Mircera.
T92	tradename 11436 11443	Mircera
T93	indication 11465 11484	anemia in adult CKD
T94	dose 11542 11552	0.6 mcg/kg
T95	routeofadministration 11590 11592	IV
T96	routeofadministration 11596 11598	SC
T97	frequency 11609 11633	once 50 every two weeks.
T98	routeofadministration 11638 11640	IV
T99	routeofadministration 11710 11712	IV
T100	tradename 11835 11842	Mircera
T101	frequency 11863 11875	once monthly
T102	frequency 11918 11932	every-two-week
T103	tradename 12055 12062	Mircera
T104	tradename 12452 12460	Mircera,
T105	tradename 12492 12499	Mircera
T106	tradename 12604 12611	Mircera
T107	indication 12633 12652	anemia in adult CKD
T108	dose 12710 12720	0.6 mcg/kg
T109	routeofadministration 12758 12760	IV
T110	routeofadministration 12764 12766	SC
T111	frequency 12785 12801	every two weeks.
T112	tradename 12856 12863	Mircera
T113	frequency 12884 12896	once monthly
T114	frequency 12939 12953	every-two-week
T115	tradename 13038 13045	Mircera
T116	tradename 13180 13187	Mircera
T117	tradename 13213 13220	Mircera
T118	frequency 13241 13261	once every two weeks
T119	frequency 13265 13277	once monthly
T120	tradename 13382 13390	Mircera,
T121	routeofadministration 13409 13411	IV
T122	routeofadministration 13415 13417	SC
T123	tradename 13516 13523	Mircera
T124	frequency 13624 13630	/week)
T125	frequency 13675 13681	/week)
T126	tradename 13683 13690	Mircera
T127	frequency 13697 13709	Once Monthly
T128	frequency 13714 13742	/month) Once Every Two Weeks
T129	frequency 13748 13764	every two weeks)
T130	tradename 13893 13900	Mircera
T131	tradename 13904 13911	Mircera
T132	tradename 13958 13965	Mircera
T133	tradename 14154 14161	Mircera
T134	tradename 14293 14300	Mircera
T135	tradename 15036 15044	Mircera.
T136	tradename 15115 15122	Mircera
T137	tradename 15234 15241	Mircera
T138	tradename 15325 15332	Mircera
T139	adversereaction 15453 15481	Pure red cell aplasia (PRCA)
T140	tradename 15515 15522	Mircera
T141	adversereaction 15630 15655	severe allergic reactions
T142	tradename 15659 15666	Mircera
T143	adversereaction 15673 15733	anaphylactic reactions, angioedema, bronchospasm, skin rash,
T144	adversereaction 15738 15748	urticaria)
T145	adversereaction 15784 15835	Increased Mortality, Myocardial Infarction, Stroke,
T146	adversereaction 15840 15855	Thromboembolism
T147	adversereaction 16031 16138	death, myocardial infarction, stroke, congestive heart failure, thrombosis of hemodialysis vascular access,
T148	adversereaction 16149 16170	thromboembolic events
T149	adversereaction 16313 16337	cardiovascular reactions
T150	adversereaction 16638 16662	cardiovascular reactions
T151	adversereaction 16667 16676	mortality
T152	adversereaction 16886 16891	death
T153	adversereaction 16913 16938	cardiovascular reactions.
T154	adversereaction 16972 16993	myocardial infarction
T155	adversereaction 16998 17005	stroke.
T156	adversereaction 17075 17080	death
T157	adversereaction 17164 17192	deep venous thrombosis (DVT)
T158	indication 20119 20136	anemia due to CKD
T159	tradename 23603 23610	Mircera
T160	adversereaction 24907 24926	Increased Mortality
T161	adversereaction 24952 24969	Tumor Progression
T162	tradename 25017 25024	Mircera
T163	tradename 25156 25163	Mircera
T164	tradename 25333 25340	Mircera
T165	activeingredient 31468 31480	epoetin beta
T166	activeingredient 31685 31697	epoetin beta
T167	activeingredient 31764 31776	epoetin beta
T168	activeingredient 31868 31880	epoetin beta
T169	tradename 32522 32529	Mircera
T170	tradename 32602 32609	Mircera
T171	adversereaction 32787 32814	Hypertensive encephalopathy
T172	adversereaction 32826 32834	seizures
T173	tradename 32888 32895	Mircera
T174	tradename 33023 33031	Mircera.
T175	tradename 33055 33062	Mircera
T176	adversereaction 33270 33278	Seizures
T177	adversereaction 33283 33291	Seizures
T178	tradename 33335 33342	Mircera
T179	tradename 33421 33429	Mircera,
T180	tradename 33684 33691	Mircera
T181	tradename 33739 33747	Mircera,
T182	adversereaction 33950 33954	PRCA
T183	adversereaction 34015 34020	PRCA,
T184	tradename 34115 34122	Mircera
T185	adversereaction 34179 34200	Pure Red Cell Aplasia
T186	adversereaction 34214 34218	PRCA
T187	adversereaction 34226 34240	severe anemia,
T188	adversereaction 34263 34273	cytopenias
T189	tradename 34437 34445	Mircera.
T190	routeofadministration 34522 34524	SC
T191	adversereaction 34545 34549	PRCA
T192	tradename 34590 34598	Mircera.
T193	adversereaction 34605 34609	PRCA
T194	tradename 34733 34740	Mircera
T195	adversereaction 34767 34780	severe anemia
T196	adversereaction 34785 34807	low reticulocyte count
T197	tradename 34838 34846	Mircera,
T198	tradename 34856 34863	Mircera
T199	tradename 35043 35050	Mircera
T200	tradename 35097 35104	Mircera
T201	company 35130 35135	Roche
T202	tradename 35242 35249	Mircera
T203	adversereaction 35274 35278	PRCA
T204	tradename 35304 35311	Mircera
T205	adversereaction 35466 35492	Serious Allergic Reactions
T206	adversereaction 35497 35524	Serious allergic reactions,
T207	adversereaction 35535 35606	anaphylactic reactions, angioedema, bronchospasm, tachycardia, pruritus
T208	adversereaction 35611 35621	skin rash,
T209	adversereaction 35626 35635	urticaria
T210	tradename 35680 35688	Mircera.
T211	tradename 35754 35762	Mircera,
T212	tradename 35803 35810	Mircera
T213	tradename 35897 35904	Mircera
T214	tradename 36112 36120	Mircera.
T215	tradename 36140 36147	Mircera
T216	tradename 36381 36388	Mircera
T217	adversereaction 37164 37215	Increased Mortality, Myocardial Infarction, Stroke,
T218	adversereaction 37220 37235	Thromboembolism
T219	adversereaction 37291 37310	Increased mortality
T220	adversereaction 37318 37335	tumor progression
T221	adversereaction 37415 37427	Hypertension
T222	adversereaction 37486 37494	Seizures
T223	adversereaction 37545 37566	Pure red cell aplasia
T224	adversereaction 37617 37643	Serious allergic reactions
T225	adversereaction 37768 37780	hypertension
T226	adversereaction 37823 37832	diarrhea,
T227	adversereaction 37837 37853	nasopharyngitis.
T228	tradename 37938 37945	Mircera
T229	adversereaction 37969 38015	hypertension, coronary artery disease, anemia,
T230	adversereaction 38069 38082	septic shock.
T231	tradename 38169 38176	Mircera
T232	tradename 38279 38286	Mircera
T233	tradename 38359 38367	Mircera,
T234	tradename 38721 38728	Mircera
T235	frequency 38754 38783	once every two or four weeks,
T236	routeofadministration 38801 38803	SC
T237	routeofadministration 38807 38810	IV.
T238	tradename 38951 38958	Mircera
T239	tradename 39257 39264	Mircera
T240	tradename 39355 39362	Mircera
T241	tradename 39479 39487	Mircera.
T242	tradename 39613 39620	Mircera
T243	adversereaction 39640 39664	Hypertension Hypotension
T244	adversereaction 39692 39722	Diarrhea Vomiting Constipation
T245	adversereaction 39764 39837	Nasopharyngitis Upper Respiratory Tract Infection Urinary Tract Infection
T246	adversereaction 39866 39874	Headache
T247	adversereaction 39920 39961	Muscle Spasms Back Pain Pain in Extremity
T248	adversereaction 40024 40119	Procedural Hypotension Arteriovenous Fistula Thrombosis Arteriovenous Fistula Site Complication
T249	adversereaction 40161 40175	Fluid Overload
T250	adversereaction 40220 40225	Cough
T251	tradename 40361 40368	Mircera
T252	tradename 40587 40594	Mircera
T253	tradename 40756 40763	Mircera
T254	tradename 41063 41071	Mircera.
T255	tradename 41107 41114	Mircera
T256	tradename 41779 41786	Mircera
T257	tradename 42108 42115	Mircera
T258	nanoparticle 42252 42292	methoxy polyethylene glycol-epoetin beta
T259	routeofadministration 42310 42324	subcutaneously
T260	dose 42417 42426	50 mcg/kg
T261	frequency 42427 42449	once every three days.
T262	dose 42841 42849	5 mcg/kg
T263	frequency 42850 42871	once every three days
T264	nanoparticle 42884 42924	methoxy polyethylene glycol-epoetin beta
T265	frequency 42981 42998	Once-weekly doses
T266	nanoparticle 43002 43046	methoxy polyethylene glycol-epoetin 373 beta
T267	dose 43053 43063	50 mcg/kg/
T268	tradename 43547 43554	Mircera
T269	nanoparticle 43613 43657	methoxy polyethylene 380 glycol-epoetin beta
T270	tradename 43775 43782	Mircera
T271	tradename 43873 43880	Mircera
T272	tradename 43977 43984	Mircera
T273	tradename 44720 44727	Mircera
T274	tradename 44893 44900	Mircera
T275	tradename 45032 45039	Mircera
T276	adversereaction 45147 45159	hypertension
T277	tradename 45281 45289	Mircera,
T278	nanoparticle 45290 45331	methoxy polyethylene glycol-epoetin beta,
T279	surfacecoating 45559 45592	methoxy polyethylene glycol (PEG)
T280	molecularweight 45626 45641	30,000 daltons)
T281	molecularweight 45701 45716	60,000 daltons.
T282	tradename 45721 45728	Mircera
T283	routeofadministration 45796 45807	intravenous
T284	routeofadministration 45811 45823	subcutaneous
T285	tradename 45873 45880	Mircera
T286	inactiveingredient 45952 46011	sodium 407 phosphate, sodium sulphate, mannitol, methionine
T287	inactiveingredient 46016 46030	poloxamer 188.
T288	tradename 46178 46185	Mircera
T289	tradename 46804 46811	Mircera
T290	tradename 47081 47088	Mircera
T291	indication 47105 47129	anemic patients with CKD
T292	tradename 47192 47199	Mircera
T293	routeofadministration 47334 47336	IV
T294	tradename 47355 47362	Mircera
T295	dose 47363 47373	0.4 mcg/kg
T296	plasmahalflife 47473 47486	134  65 hours
T297	clearance 47536 47560	427 0.49  0.18 mL/hr/kg.
T298	routeofadministration 47573 47575	SC
T299	tradename 47594 47601	Mircera
T300	dose 47602 47612	0.8 mcg/kg
T301	plasmahalflife 47691 47705	139  67 hours.
T302	tradename 47742 47749	Mircera
T303	tmax 47768 47776	72 hours
T304	routeofadministration 47806 47808	SC
T305	tradename 47861 47868	Mircera
T306	routeofadministration 47879 47881	SC
T307	tradename 47947 47954	Mircera
T308	tradename 48157 48165	Mircera.
T309	tradename 48220 48227	Mircera
T310	frequency 48276 48293	every four weeks.
T311	tradename 48308 48315	Mircera
T312	frequency 48333 48347	every 2 weeks,
T313	tradename 48453 48460	Mircera
T314	tradename 48622 48629	Mircera
T315	routeofadministration 48768 48770	SC
T316	tradename 48892 48899	Mircera
T317	tradename 49097 49105	Mircera.
T318	nanoparticle 49106 49150	Methoxy polyethylene glycol-445 epoetin beta
T319	nanoparticle 49407 49447	methoxy polyethylene glycol-epoetin beta
T320	nanoparticle 49513 49553	methoxy polyethylene glycol-epoetin beta
T321	routeofadministration 49571 49585	subcutaneously
T322	tradename 51532 51539	Mircera
T323	tradename 52464 52471	Mircera
T324	tradename 52574 52581	Mircera
T325	indication 52625 52649	anemic patients with CKD
T326	indication 52798 52812	anemia of CKD.
T327	tradename 53398 53405	Mircera
T328	tradename 53581 53588	Mircera
T329	tradename 53662 53669	Mircera
T330	dose 53674 53684	0.6 mcg/kg
T331	routeofadministration 53698 53700	SC
T332	frequency 53701 53725	once every two 495 weeks
T333	dose 53772 53783	0.45 mcg/kg
T334	routeofadministration 53797 53799	SC
T335	frequency 53800 53812	once a week.
T336	tradename 53885 53892	Mircera
T337	activeingredient 53925 53938	epoetin beta)
T338	tradename 53992 53999	Mircera
T339	dose 54004 54014	0.4 mcg/kg
T340	routeofadministration 54028 54030	IV
T341	frequency 54031 54051	once every two weeks
T342	routeofadministration 54113 54115	IV
T343	frequency 54116 54135	three times a week,
T344	tradename 54234 54241	Mircera
T345	frequency 54242 54262	once every two weeks
T346	dose 54323 54334	0.6 mcg/kg.
T347	tradename 54577 54584	Mircera
T348	tradename 54669 54676	Mircera
T349	activeingredient 54706 54723	Epoetin alfa/beta
T350	tradename 55033 55040	Mircera
T351	tradename 55169 55176	Mircera
T352	frequency 55200 55224	once every two 508 weeks
T353	frequency 55228 55250	once every four weeks,
T354	tradename 55315 55322	Mircera
T355	tradename 55432 55439	Mircera
T356	frequency 55444 55464	once every two weeks
T357	frequency 55469 55490	once every four weeks
T358	tradename 55803 55810	Mircera
T359	routeofadministration 55811 55813	IV
T360	frequency 55814 55827	every 2 weeks
T361	tradename 55871 55878	Mircera
T362	routeofadministration 55879 55881	IV
T363	frequency 55882 55895	every 4 weeks
T364	activeingredient 55939 55956	Epoetin alfa/beta
T365	routeofadministration 55957 55959	IV
T366	tradename 55992 55999	Mircera
T367	frequency 56003 56016	every 2 weeks
T368	tradename 56060 56067	Mircera
T369	routeofadministration 56068 56070	SC
T370	frequency 56071 56084	every 4 weeks
T371	activeingredient 56136 56148	Epoetin beta
T372	routeofadministration 56149 56151	SC
T373	tradename 56183 56190	Mircera
T374	routeofadministration 56191 56193	IV
T375	frequency 56194 56207	every 2 weeks
T376	routeofadministration 56268 56270	IV
T377	tradename 56303 56310	Mircera
T378	routeofadministration 56311 56316	IV/SC
T379	frequency 56317 56330	every 2 weeks
T380	routeofadministration 56388 56393	IV/SC
T381	tradename 56442 56449	Mircera
T382	tradename 56575 56582	Mircera
T383	tradename 56770 56777	Mircera
T384	tradename 57151 57158	Mircera
T385	tradename 57716 57723	Mircera
T386	tradename 58104 58112	Mircera.
T387	tradename 58282 58289	Mircera
T388	tradename 58331 58338	Mircera
T389	adversereaction 58385 58395	mortality,
T390	adversereaction 58404 58463	cardiovascular reactions, thromboembolic reactions, stroke,
T391	adversereaction 58473 58490	tumor progression
T392	tradename 58817 58824	Mircera
T393	tradename 59084 59091	Mircera
T394	tradename 59215 59222	Mircera
T395	tradename 59273 59281	Mircera,
T396	tradename 59472 59479	Mircera
T397	tradename 59707 59714	MIRCERA
T398	nanoparticle 59733 59774	methoxy polyethylene glycol-epoetin beta)
T399	tradename 59845 59853	Mircera.
T400	tradename 59948 59956	Mircera.
T401	tradename 60034 60041	Mircera
T402	tradename 60338 60345	Mircera
T403	tradename 60388 60396	Mircera.
T404	tradename 60465 60473	Mircera?
T405	tradename 60478 60485	Mircera
T406	tradename 60580 60587	Mircera
T407	tradename 60757 60765	Mircera.
T408	tradename 60902 60909	Mircera
T409	tradename 61074 61082	Mircera.
T410	tradename 61108 61115	Mircera
T411	tradename 62297 62305	Mircera?
T412	tradename 62361 62369	Mircera,
T413	tradename 62437 62444	Mircera
T414	tradename 62562 62570	Mircera?
T415	tradename 62575 62582	Mircera
T416	tradename 62697 62704	Mircera
T417	tradename 62794 62801	Mircera
T418	tradename 62864 62871	Mircera
T419	tradename 63200 63208	Mircera,
T420	tradename 63275 63282	Mircera
T421	tradename 63470 63477	Mircera
T422	tradename 63577 63584	Mircera
T423	tradename 63649 63657	Mircera?
T424	tradename 63674 63681	Mircera
T425	tradename 63958 63965	Mircera
T426	tradename 64066 64073	Mircera
T427	tradename 64139 64147	Mircera?
T428	tradename 64152 64159	Mircera
T429	tradename 64560 64567	Mircera
T430	tradename 64674 64681	Mircera
T431	tradename 65051 65059	Mircera?
T432	tradename 65123 65130	Mircera
T433	tradename 65259 65267	Mircera.
T434	tradename 65281 65288	Mircera
T435	tradename 65369 65376	Mircera
T436	tradename 65484 65491	Mircera
T437	tradename 65682 65690	Mircera,
T438	tradename 65804 65812	Mircera,
T439	tradename 66089 66097	Mircera?
T440	tradename 66102 66109	Mircera
T441	tradename 66220 66228	Mircera?
T442	tradename 66312 66319	Mircera
T443	tradename 66469 66477	Mircera.
T444	adversereaction 66751 66760	Seizures.
T445	adversereaction 66777 66785	seizures
T446	tradename 66799 66807	Mircera,
T447	tradename 66941 66949	Mircera.
T448	tradename 67115 67122	Mircera
T449	tradename 67195 67203	Mircera.
T450	tradename 67237 67245	Mircera.
T451	adversereaction 67365 67372	anemia.
T452	tradename 67505 67513	Mircera.
T453	adversereaction 67528 67581	Serious allergic reaction. Serious allergic reactions
T454	adversereaction 67594 67598	rash
T455	adversereaction 67625 67665	shortness of breath, wheezing, dizziness
T456	adversereaction 67670 67678	fainting
T457	adversereaction 67720 67728	swelling
T458	adversereaction 67756 67767	fast pulse,
T459	adversereaction 67771 67780	sweating.
T460	adversereaction 67795 67825	serious allergic 680 reaction,
T461	tradename 67837 67844	Mircera
T462	tradename 67954 67961	Mircera
T463	adversereaction 67985 67993	Diarrhea
T464	adversereaction 68008 68042	Upper respiratory tract infections
T465	tradename 68248 68256	Mircera.
T466	tradename 68565 68573	Mircera?
T467	tradename 68593 68600	Mircera
T468	tradename 68724 68731	Mircera
T469	tradename 68854 68862	Mircera.
T470	tradename 68874 68881	Mircera
T471	tradename 68950 68957	Mircera
T472	tradename 69006 69013	Mircera
T473	tradename 69053 69061	Mircera.
T474	tradename 69071 69078	Mircera
T475	tradename 69162 69169	Mircera
T476	tradename 69284 69291	Mircera
T477	tradename 69353 69360	Mircera
T478	tradename 69525 69533	Mircera.
T479	tradename 69579 69587	Mircera,
T480	tradename 69701 69708	Mircera
T481	tradename 69793 69801	Mircera?
T482	nanoparticle 69825 69865	methoxy polyethylene glycol-epoetin beta
T483	inactiveingredient 69892 69947	sodium phosphate, sodium sulphate, mannitol, methionine
T484	inactiveingredient 69956 69969	poloxamer 188
T485	company 70071 70093	Hoffmann-La Roche Inc.
T486	company 70102 70116	Genentech USA,
T487	company 70142 70153	Roche Group
T488	company 70304 70326	Hoffmann-La Roche Inc.
T489	tradename 70446 70453	Mircera
T490	adversereaction 70538 70557	Increased Mortality
T491	adversereaction 70583 70600	Tumor Progression
T492	adversereaction 70745 70757	Hypertension
T493	adversereaction 70763 70771	Seizures
T494	tradename 70816 70823	Mircera
T495	adversereaction 70829 70850	Pure Red Cell Aplasia
T496	adversereaction 70856 70882	Serious Allergic Reactions
